Loading...
OTCM
BDABF
Market cap22mUSD
Mar 27, Last price  
3.51USD
Name

Boule Diagnostics AB

Chart & Performance

D1W1MN
OTCM:BDABF chart
P/E
P/S
2.29
EPS
Div Yield, %
Shrs. gr., 5y
7.21%
Rev. gr., 5y
2.29%
Revenues
559m
-2.23%
168,693,500175,391,166229,421,000246,155,000275,301,000276,804,000306,687,000331,407,000400,735,000427,793,000424,400,000498,916,000400,458,000463,344,000548,088,000571,329,000558,600,000
Net income
-223m
L
-5,549,061-10,548,23318,891,00011,711,00010,959,000-70,125,00030,265,00015,352,00036,033,00037,239,00041,031,00037,548,000-47,965,00023,272,00012,728,00024,977,000-223,300,000
CFO
47m
-9.30%
4,310,8948,203,59716,159,0005,444,00010,948,00015,675,00030,985,00022,324,00019,875,00057,715,00022,663,00053,976,00075,239,00043,284,000-11,353,00051,377,00046,600,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Boule Diagnostics AB (publ), a diagnostics company, develops, manufactures, and markets instruments and consumable products for blood diagnostics. The company provides hematology analyzers, reagents, blood controls and calibrators, and reagents rotors, as well as cleaning products under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer and diagnostics systems under the Exigo brand. It sells its products directly in Sweden and the United States, as well as through distributors internationally. The company serves hospitals, clinics, laboratories, healthcare centers and veterinary clinics, and other diagnostics companies. It has operations in Sweden, the United States, Mexico, and Russia. The company was founded in 1956 and is headquartered in Spånga, Sweden.
IPO date
Jun 23, 2011
Employees
200
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT